Want to see HK:2190 full AI Analyst Report?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (2190) Financial Statements
Zylox-Tonbridge Medical Technology Co., Ltd. Class H Financial Overview
Zylox-Tonbridge Medical Technology Co., Ltd. Class H's market cap is currently $6.41B. The company's EPS TTM is $0.95; its P/E ratio is 16.65; and it has a dividend yield of 1.93%. Zylox-Tonbridge Medical Technology Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.06B | $ 782.48M | $ 527.75M | $ 334.09M | $ 177.91M |
| Gross Profit | $ 762.92M | $ 559.89M | $ 384.99M | $ 252.67M | $ 131.88M |
| Operating Income | $ 196.64M | $ 60.91M | $ -156.52M | $ -208.40M | $ -212.48M |
| EBITDA | $ 236.08M | $ 74.03M | $ -41.60M | $ -86.56M | $ -204.78M |
| Net Income | $ 244.37M | $ 100.26M | $ -78.73M | $ -113.56M | $ -199.69M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.73B | $ 1.28B | $ 1.51B | $ 1.86B | $ 2.93B |
| Total Assets | $ 3.58B | $ 3.45B | $ 3.38B | $ 3.25B | $ 3.25B |
| Total Debt | $ 63.67M | $ 90.91M | $ 55.88M | $ 14.00M | $ 9.40M |
| Net Debt | $ -516.14M | $ -327.20M | $ -1.03B | $ -1.19B | $ -1.41B |
| Total Liabilities | $ 343.98M | $ 351.56M | $ 328.32M | $ 159.54M | $ 103.61M |
| Stockholders' Equity | $ 3.23B | $ 3.10B | $ 3.05B | $ 3.09B | $ 3.14B |
| Cash Flow | |||||
| Free Cash Flow | $ 268.72M | $ -17.26M | $ -92.48M | $ -236.60M | $ -205.80M |
| Operating Cash Flow | $ 377.07M | $ 174.08M | $ 98.44M | $ -91.32M | $ -116.21M |
| Investing Cash Flow | $ -46.54M | $ -801.36M | $ -206.24M | $ -95.05M | $ -1.33B |
| Financing Cash Flow | $ -168.64M | $ -41.98M | $ -11.46M | $ -30.26M | $ 2.81B |
Currency in CNY